Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02379143
Other study ID # 1
Secondary ID
Status Completed
Phase N/A
First received February 19, 2015
Last updated February 26, 2015
Start date September 2013
Est. completion date March 2014

Study information

Verified date February 2015
Source TPCT's Terna College of Physiotherapy
Contact n/a
Is FDA regulated No
Health authority India: Institutional Review Board
Study type Observational

Clinical Trial Summary

Various national & international bodies like FDA, CSP has laid down the guidelines for the reasonable use of SWD electro therapeutic agent (EPA) ensuring safety & effectiveness.

However, it remains uncertain, whether the practicing physiotherapists are aware of the very existence of this guidelines and implementing them in daily practice. Any lack of knowledge about this background can endanger the patient safety leading to serious health hazards.

In the present survey, 49 physiotherapy practitioners were interviewed with a self-report measure to investigate their knowledge base, mode of application of SWD (6 items) & the awareness about recommended guidelines (5 items) etc.


Description:

Study design: cross sectional survey design with the use of a self-report form to record the participant's views was used. Sampling frame consisted of physiotherapists working in private clinics in sub-urban area of Mumbai, Maharashtra, India.

Institutional ethic committee of Terna Physiotherapy College granted permission to conduct this survey. The self-report forms were coded in order to conceal the identity of the therapist.

In this survey 49 physiotherapists were interviewed with a self-report form consisting of total 23 item. In the initial section of this survey form a general information was collected regarding years of experience (1 item), Types of condition treated (1 item), No of patients treated (item 1) Duration of onset (item 1) & the type of modality used (item 1). Specific items interrogating therapist's knowledge about the EMF generating modality were designed to retrieve the information about dosage prescription (7 item), acquaintance with recommended guidelines & indications (item 5), years of experience with that particular modality (item1), Any kind of side effects observed (item 1), any action taken for the same (item 2), referring personnel for recommending this modality (item 1), overall therapist's experience with the effectiveness of this modality (item1).


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date March 2014
Est. primary completion date March 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 25 Years to 60 Years
Eligibility Inclusion Criteria:

- Private physical therapists practitioners

Exclusion Criteria:

- Who were volunteering to participate

Study Design

Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Other:
interview method: self report form
the responses about participants perception, behavior pattern and attitude were recorded on the self report form

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
TPCT's Terna College of Physiotherapy

References & Publications (1)

Bibliography: 1. William E. Prentice PD P, ATC, Professor. Therapeutic Modalities for Physical Therapists. University of North Carolina Chapel Hill, North Carolina. : McGraw-Hill Medical,medical publishing division; 2001. 576 p. 2. Bioelectronics Corporat

Outcome

Type Measure Description Time frame Safety issue
Primary SELF REPORT FORM This 23 item form was prepared after the extensive discussion with the panel of experts. In the initial section of this survey form a general information was collected regarding years of experience (1 item), Types of condition treated (1 item), No of patients treated (item 1) Duration of onset (item 1) & the type of modality used (item 1). Specific items interrogating therapist's knowledge about the EMF generating modality were designed to retrieve the information about dosage prescription (7 item), acquaintance with recommended guidelines & indications (item 5), years of experience with that particular modality (item1), Any kind of side effects observed (item 1), any action taken for the same (item 2), referring personnel for recommending this modality (item 1), overall therapist's experience with the effectiveness of this modality (item1). ONE DAY. 15 MINUTES No
See also
  Status Clinical Trial Phase
Completed NCT05554874 - Effect of Pulsed Electromagnetic Stimulation on DOMS N/A
Completed NCT03537469 - Neuromodulation With Low Frequency-Pulsed Electromagnetic Fields Early Phase 1